Glioblastoma (GBM) treatment faces challenges due to drug resistance. Here, the authors show that lysine-arginine balance supports lysosomes mediated tolerance to temozolomide and lysine restriction mimetic increases anticancer therapies in GBM preclinical models.
- Yongwei Jing
- Masahiko Kobayashi
- Atsushi Hirao
